Request Demo
Last update 29 Oct 2026
Guangzhou Lansheng Jianzhi Pharmaceutical Technology
Private Company|2012|Jiangsu Sheng, China
Private Company|2012|Jiangsu Sheng, China
Last update 29 Oct 2026
Overview
Tags
Nervous System Diseases
Small molecule drug
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
CTR20260888
评价健康参与者单次口服LS21031胶囊的安全性、耐受性及药代动力学特征的临床研究
[Translation] Clinical study evaluating the safety, tolerability, and pharmacokinetic characteristics of a single oral dose of LS21031 capsules in healthy participants.
CTR20220065
左旋盐酸去甲基苯环壬酯片在早、中期帕金森病患者中的安全性、耐受性和药代动力学Ⅰ期临床研究
[Translation] Phase I clinical study on the safety, tolerability and pharmacokinetics of levorotatory demethylphencyclonate hydrochloride tablets in patients with early and middle stage Parkinson's disease
ChiCTR2200055662
Phase I clinical study on the safety, tolerability and pharmacokinetics of L-desmethylphencyclonate hydrochloride tablets in patients with early and middle stage Parkinson's disease
100 Clinical Results associated with Guangzhou Lansheng Jianzhi Pharmaceutical Technology
Login to view more data
Login to view more data
100 Deals associated with Guangzhou Lansheng Jianzhi Pharmaceutical Technology
Login to view more data
100 Translational Medicine associated with Guangzhou Lansheng Jianzhi Pharmaceutical Technology
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 01 Nov 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Preclinical
2
1
Phase 1
Phase 2
1
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free